quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:16·617d
SECFiling
Viracta Therapeutics Inc. logo

SEC Form 10-Q filed by Viracta Therapeutics Inc.

VIRX· Viracta Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • VIRX
    Viracta Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Aug 16UpdateLeerink Partners$3.00
  • Feb 1UpdateRBC Capital Mkts$10.00

Related

  • SEC442d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR442d
    Viracta Therapeutics Announces Wind Down of Operations
  • SEC447d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC454d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Financial Statements and Exhibits
  • SEC461d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC483d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Other Events, Financial Statements and Exhibits
  • PR483d
    Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives
  • SEC510d
    Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022